Epidiolex maker GW Pharma reports record quarterly revenue of $137 million
United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales…
News November 4
Latest In: United Kingdom
Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact
United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges…
News August 7
UK down-schedules Epidyolex to lowest level for controlled drugs
The United Kingdom has down-scheduled Epidyolex to the lowest level of control for drugs, greatly easing restrictions on…
News June 24
Many Europeans stockpiled illicit cannabis as COVID-19 set in, report suggests
Regular cannabis users in Europe might have stocked up on illegal products as the COVID-19 pandemic started to sweep…
News May 8
Australian cannabis company completes first export to UK
West Perth-based Little Green Pharma said it completed the first-ever commercial export of Australian-produced medical cannabis oil to…
News April 17
New Zealand eases prescription requirement for cannabis-based medicine Sativex
Doctors in New Zealand no longer require Ministry of Health approval to prescribe Sativex, according to a new…
News April 9
COVID-19 crisis effectively freezes European GMP cannabis inspections in Canada, elsewhere
European Union Good Manufacturing Practice (EU-GMP) certification audits involving cannabis facilities in Canada and elsewhere are screeching to a…
News April 6
Postponed vote on WHO cannabis recommendations reveals international disagreements, uphill battle ahead
The 63rd session of the United Nations Commission on Narcotic Drugs (CND) in Vienna this week laid bare deep…
News March 6
UK eases import restrictions for medical cannabis
The United Kingdom is easing import restrictions for medical cannabis, a move that is expected to improve the…
News March 2Featured
1
Latest Sponsored
